Shares Magazine
|
|
Hemogenyx Pharmaceuticals Plc = |
Click on a deal for more details.
Hemogenyx Pharmaceuticals Director Holdings
| Name | Position | Appointed | Last Deal | Total % | Shares Held | Total Value (£) |
|---|---|---|---|---|---|---|
| Peter Redmond | Non Executive Director | 2015 | 30/01/20 | 1.55 | 5,596,270 | 517,655 |
| Vladislav Sandler | Chief Executive Officer | 2017 | 03/07/19 | 32.29 | 116,635,362 | 10,788,771 |
Hemogenyx Pharmaceuticals Director Deals
Set up a new alert »| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|---|---|---|---|---|
| 30/01/20 | PLAC | Peter Redmond | NED | 555,556 @ 1.80p | £10,000.00 |
| 03/07/19 | TIN | Vladislav Sandler | CEO | 1,066,667 @ 0p | £0.00 |
| 12/02/18 | BUY | Adrian Thorpe Beeston | RES | 200,000 @ 2.10p | £4,200.00 |
| 07/02/18 | BUY | Vladislav Sandler | CEO | 26,800 @ 2.37p | £635.00 |
| 11/10/17 | BUY | Adrian Thorpe Beeston | RES | 400,000 @ 2.96p | £11,840.00 |
| 10/10/17 | BUY | Peter Redmond | NED | 155,000 @ 3.14p | £4,859.00 |
| 10/10/17 | BUY | Adrian Thorpe Beeston | RES | 317,683 @ 3.10p | £9,848.00 |
Showing 1 to 7 of 7
Sign up to our
daily email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
